ClinicalTrials.Veeva

Menu

Development of an Educational Video Game to Improve Nursing Students' Reasoning With Acute Heart Failure Patients

M

Marc-André Maheu-Cadotte

Status

Completed

Conditions

Motivation
Heart Failure

Treatments

Other: SIGN@L-A
Other: SIGN@L-B

Study type

Interventional

Funder types

Other

Identifiers

NCT04592432
CERSES-20-123-D

Details and patient eligibility

About

The aim of this study is to appreciate, using quantitative and qualitative empirical methods, the contribution of an educational video game to the engagement, the motivation, and the development of nursing students' interpretation of acute heart failure patients' health condition. Two prototypes of the same educational video game have been developed. Study participants will play with both prototypes, complete online questionnaires and be interviewed by a research assistant regarding their experience with both prototypes. Study results will serve to select the most promising prototype between the two, based on its potential to support the engagement, the motivation, and the development of nursing students' interpretation of acute heart failure patients' health condition. Study results will also serve to refine the selected prototype before conducting a larger-scale efficacy trial. As such and given the small sample number of participants that is expected, it is not planned to conduct hypothesis testing.

Enrollment

28 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • As part of a Bachelor of Nursing program, to be registered in a course in which acute heart failure concepts are a focus.

Exclusion criteria

  • No exclusion criteria

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

28 participants in 2 patient groups

SIGN@L-A followed by SIGN@L-B
Experimental group
Description:
Participants in this arm will have access to the prototype "SIGN@L-A" of the serious game for seven days. They will have access to this prototype from their personal computer and will be able to play with it whenever they want and for how long they wish during this period. After these seven days, they will have access the same way to the prototype "SIGN@L-B".
Treatment:
Other: SIGN@L-B
Other: SIGN@L-A
SIGN@L-B followed by SIGN@L-A
Experimental group
Description:
Participants in this arm will have access to the prototype "SIGN@L-B" of the serious game for seven days. They will have access to this prototype from their personal computer and will be able to play with it whenever they want and for how long they wish during this period. After these seven days, they will have access the same way to the prototype "SIGN@L-A".
Treatment:
Other: SIGN@L-B
Other: SIGN@L-A

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems